SCHEMBL4554543

SCHEMBL4554543

Cc1cccn2cc(-c3ccc(CC(CN)NC(=O)c4ccc(OC(C)C)c(Cl)c4)cc3)nc12

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CENPE Q02224 3/20 0.68
ALDH1A1 P00352 7/20 0.47
KDM4E B2RXH2 7/20 0.47
KMT2A Q03164 2/20 0.47
MAPT P10636 2/20 0.47
HPGD P15428 2/20 0.47
MEN1 O00255 1/20 0.42
NPC1 O15118 7/20 0.42
RAB9A P51151 7/20 0.42
PKM P14618 1/20 0.42
SMN1; SMN2 Q16637 4/20 0.41
TP53 P04637 3/20 0.41
KIFC1 Q9BW19 1/20 0.40
POLB P06746 1/20 0.40
NFKB1 P19838 3/20 0.40
NFKB2 Q00653 3/20 0.40
RELA Q04206 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
RECQL P46063 1/20 0.40
HRH3 Q9Y5N1 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2102560 1.00 CENPE (0.68) CENPEALDH1A1KDM4EKMT2AMAPT
SCHEMBL2104936 0.93 CENPE (0.71) CENPEALDH1A1KDM4EKMT2AMAPT
SCHEMBL2104390 0.92 CENPE (0.65) CENPEALDH1A1KDM4EKMT2AMAPT
SCHEMBL4761956 0.92 CENPE (0.65) CENPEALDH1A1KDM4EKMT2AMAPT
SCHEMBL3462266 0.92 CENPE (0.80) CENPEALDH1A1KDM4EKMT2AMAPT
SCHEMBL2104176 0.92 CENPE (0.80) CENPEALDH1A1KDM4EKMT2AMAPT
SCHEMBL2100836 0.91 CENPE (0.69) CENPEALDH1A1KDM4EKMT2AMAPT
SCHEMBL2617335 0.91 CENPE (0.69) CENPEALDH1A1KDM4EKMT2AMAPT
SCHEMBL2104360 0.91 CENPE (0.78) CENPEALDH1A1KDM4EKMT2AMAPT
SCHEMBL2104839 0.90 CENPE (0.69) CENPEALDH1A1KDM4EKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7618981-B2 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide CYTOKINETICS, INC. (US) 2009-11-17 US disclosed